The elevating demand for skincare treatment devices is attributed to the rising prevalence of skin disorders, flourishing beauty industry, the increasing demand for aesthetic treatments, and the growing preference for minimally and noninvasive beauty treatments. Furthermore, a surge in research and development activities, and strategic collaborations among various market players are leading to product developments and launches in the European skincare devices market. In March 2022, Lumenis Be, Ltd., announced the launch of triLift, a facial stimulation device targeting the three aging parameters—structure, contour, and texture—by treating the muscle layer, the dermal layer, and the epidermal layer. Lumenis unveiled this new device at the 2022 AAD Annual Meeting’s show floor. In January 2022, Obagi announced the launch of Skintrinsiq, its first entry into the skincare devices market. The Skintrinsiq device extracts impurities from the skin and increases Obagi product penetration by infusing them via customized skincare treatments. It uses InfuseIQ Technology to gently lift the upper layers of the skin, aiding the removal of impurities. Such product developments and launches are contributing to the skincare treatment devices market growth in Europe.
With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe Skincare treatment devices market at a substantial CAGR during the forecast period.
Europe Skincare Treatment Devices Market Segmentation
The Europe skincare treatment devices market is segmented on the basis of product, application, distribution channel, end user, and country. Based on product, the market is segmented into light/LED therapy and photo rejuvenation devices, liposuction devices, electrosurgical devices, microdermabrasion devices, laser based devices, and cryotherapy devices. In 2021, the laser based devices segment held a larger share of the market; and it is also expected to register a higher CAGR during the forecast period. Based on application, the Europe skincare treatment devices market is segmented into cellulite reduction, hair removal, skin rejuvenation, skin tightening and body contouring, and others. In 2021, the hair removal segment held the largest market share; and the skin tightening and body contouring segment is expected to register the highest CAGR in the market during the forecast period. Based on distribution channel, the Europe skincare treatment devices market is segmented into online retails, specialty stores, supermarkets/ hypermarkets, and other sales channel. In 2021, the specialty stores segment held the largest market share; and the online retails segment is expected to register the highest CAGR in the market during the forecast period. Based on end user, the market is segmented into dermatology clinics, hospitals, spas & salons, and others. In 2021, the dermatology clinics segment held a larger share of the market; and the same segment is expected to register a higher CAGR during the forecast period. Based on country, the Europe skincare treatment devices market is segmented into the U.K., Germany, France, Italy, Spain, and Rest of Europe. In 2021, Germany held the largest market share; and the UK is expected to grow at the fastest CAGR during the forecast period.
Allergan Plc; Cutera, Inc.; Merz Pharma; Hologic, Inc.; Candela Medical; Panasonic Corporation; Michelson Diagnostics Ltd.; Bausch Health Companies Inc.; and Lumenis Be Ltd. are among the leading companies in the Europe skincare treatment devices market.